Articles tagged "Kidney transplantation"

2019 American Transplant Congress
Sirolimus (SRL) versus Everolimus (EVR) versus Mycophenolate (MPA) in Kidney Transplant Recipients Receiving Anti-Thymocyte Globulin Induction (r-ATG), Tacrolimus (TAC), and Prednisone
C. Rosso Felipe, L. Viana, M. Pontello Cristelli, J. Toniato, K. Ficher, S. Poletto, H. Proença, R. de Marco, M. Gerbase-Lima, A. Brigido, J. Medina Pestana, H. Tedesco-Silva
Hospital do Rim, Nephrology Division, EPM - UNIFESP, São Paulo, Brazil
*Purpose: TAC and MPA combination is considered the standard of care immunosuppressive regimen in the majority of transplant centers worldwide. Yet, given the lack of…
2019 American Transplant Congress
Ceria-Zirconia Nanoparticles as an Enhanced Antioxidant Attenuates Apoptosis of Human Kidney Proximal Tubular Epithelial Cells in Hypoxia
S. Yoon¹, K. Yoon², S. Hong³, S. Yun¹, W. Hwang¹, J. Moon⁴, J. Lee¹, H. Jeon¹
¹Nephrology, Konyang University Hospital, Daejeon, Korea, Republic of, ²Hannam University, Daejeon, Korea, Republic of, ³Chemistry, Hannam University, Daejeon, Korea, Republic of, ⁴General Surgery, Konyang University Hospital, Daejeon, Korea, Republic of
*Purpose: Ischemia/reperfusion injury, resulting from hypoxic damage within a graft, is the leading cause of delayed graft function and graft rejection. Various mechanisms have been…
2019 American Transplant Congress
Comparison between Urine and Blood NGAL for Early Prediction of Delayed Graft Function in Adult Kidney Transplant Recipients: A Systematic Review and Meta-Analysis
Y. Li, Y. Li, L. Yan, H. Wang, X. Wu, J. Tang, L. Wang, Y. Shi
Department of Laboratory Medicine, West China Hospital, Chengdu, China
*Purpose: Neutrophil gelatinase-assoicated lipocalin (NGAL) appears to be a promising proximal tubular injury biomarker for early prediction of delayed graft function (DGF) in kidney transplant…
2019 American Transplant Congress
Organ-Procurement Organization and Donor Factor-Related Variation in Deceased Donor Kidney Biopsies and Discards: A National Practice Patterns Analysis
K. Lentine¹, A. Naik², M. Schnitzler¹, H. Randall¹, J. Wellen³, B. Kasiske⁴, G. Marklin⁵, D. Brockmeier⁵, M. Cooper⁶, H. Xiao¹, Z. Zhang¹, R. Gaston⁶, R. Rothweiler⁵, D. Axelrod⁷
¹Saint Louis Univ, St. Louis, MO, ²Univ of Michigan, Ann Arbor, MI, ³Washington Univ, St. Louis, MO, ⁴SRTR, Minneapolis, MN, ⁵Mid-America Transplant, St. Louis, MO, ⁶Georgetown Univ, Washington, DC, ⁷Univ of Iowa, Iowa City, IA
*Purpose: The clinical utility and outcome implications of deceased donor kidney allograft procurement biopsies are controversial.*Methods: We analyzed Scientific Registry of Transplant Recipients data (n=59,328…
2019 American Transplant Congress
Successful Use of Nonantigen Specific Immunoadsorption In ABO-Incompatible Desensitization and Humoral Rejection Treatment in Kidney Transplantation
E. Montagud-Marrahi
Servei de Nefrologia i Trasplantament Renal, Hospital Clínic de Barcelona, Barcelona, Spain
*Purpose: : Immunoadsorption (IA) is an apheresis procedure that has been shown to be effective in the ABO incompatible living donor kidney transplantation (ABOi LDKT)…
2019 American Transplant Congress
Low Dose Anti-Thymocyte Globulin is Enough to Prevent Acute Cellular Rejection in Kidney Transplant
P. W. Baron¹, J. Weissman², F. Fazeli³, C. Zuppan⁴, R. Villicana³, P. Wai¹, L. Beeson⁵, M. De Vera¹
¹Surgery/Transplantation Institute, Loma Linda University Health, Loma Linda, CA, ²Pharmacy, Loma Linda University Health, Loma Linda, CA, ³Transplantation Institute, Loma Linda University Health, Loma Linda, CA, ⁴Pathology, Loma Linda University Health, Loma Linda, CA, ⁵Center for Nutrition, Healthy Lifestyle and Disease Prevention/School of Public Health, Loma Linda University Health, Loma Linda, CA
*Purpose: Rabbit anti-thymocyte globulin (rATG) cumulative dose needed to effectively and safely prevent acute cellular rejection is unknown. This study compares the efficacy of total…
2019 American Transplant Congress
Risk of Opportunistic Infection in Kidney Transplant Recipients with Cytomegalovirus Infection and Associated Outcomes
M. Jorgenson¹, J. Descourouez¹, B. Cardinale², B. Lyu³, B. Astor³, N. Garg³, C. Saddler³, J. Smith³, D. Mandelbrot³
¹UW Health, Madison, WI, ²University of Wisconsin-Madison School of Pharmacy, Madison, WI, ³University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI
*Purpose: Cytomegalovirus (CMV) infection in kidney transplant recipients has been anecdotally observed with concomitant or subsequent opportunistic infections (OI), but this association has yet to…
2019 American Transplant Congress
Evolution Of Right Laparoscopic Nephrectomy, Report Of A Tertiary Care Center In Mexico
L. Noriega- Salas, J. Cruz-Santiago, M. Quiñones-Gamero, J. Barcena, M. De Gante, G. Bernaldez-Gomez
Transplant Department, Instituto Mexicano Del Seguro Social, Mexico City, Mexico
*Purpose: Aim: The minimally-invasive approach to donor nephrectomy has been primarily driven for nephrectomy in the living donor; nevertheless, Right Nephrectomy (RN) constitutes a major…
2019 American Transplant Congress
Causes of 30 Day Graft Loss among Shared Kidneys in the National Kidney Registry (NKR)
J. Verbesey¹, A. Thomas², M. Ronin³, D. Segev⁴, A. Waterman⁵, S. Flechner⁶, M. Cooper¹
¹Georgetown University Hospital, Washington, DC, ²University of North Carolina, Chapel Hill, NC, ³National Kidney Registry, New York, NY, ⁴Johns Hopkins University, Baltimore, MD, ⁵UCLA, Los Angeles, CA, ⁶Cleveland Clinic, Cleveland, OH
*Purpose: We have previously reported favorable 1 year graft survival of over 98% in the NKR. Many early concerns associated with organ travel, longer ischemic…
2019 American Transplant Congress
Breakthrough Changes in the Access to Transplantation for the Patients with Atypical Hemolytic Uremic Syndrome in the Eculizumab Era
J. Zuber, M. Frimat, P. Gatault, N. Kamar, L. Couzi, N. Jourde-Chiche, V. Chatelet, S. Caillard, R. Gaisne, D. Bertrand, J. Bamoulid, M. Louis, C. Pouteil-Noble, C. Legendre, M. Peraldi, E. Rondeau, M. Le Quintrec, V. Frémeaux-Bacchi
On behalf of the French aHUS Study Group, France, France
*Purpose: Eculizumab has revolutionized the management of atypical Hemolytic Uremic Syndrome (aHUS). In 2012, the French aHUS Study Group issued recommendations to advocate a pro-transplantation…